Skip to main content
OpenTrials
Completed

NCT Number: NCT04456010

COVID-19 in ART: Perception and Experience

Non-urgent medical care, such as fertility treatments, has been massively postponed during the past weeks due to the COVID19 pandemic. The lockdown and the closure of IVF centers might cause anxiety and depression among infertile couples, who are already exposed to the distressing experience of infertility and for whom the wait for a baby already appears unending. Few data are available regarding the impact of SARS-CoV-2 on pregnant women and foetus, or on fertility.

This study aims to assess the views of infertile couple regarding the potential risks of COVID during their fertility treatment and their personal experience of the COVID pandemic and their expectation for further treatment .

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 ART COVID-19 Coronaviridae Infections Coronavirus Infections Fertility Issues Genital Diseases Infections Infertility Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Urogenital Diseases Virus Diseases

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Uhmontpellier

Montpellier, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women who had a fertility treatment prescribed during the past 9 months in our Fertility department

Exclusion criteria

  • Patient attending for a fertility preservation
  • Patient attending for a preimplantation genetic testing (PGT-M or PGT-SR)
  • Patient not fluent in French

Treatment and study plan

Questionnaire

Other

Eligible patients will be selected from our electronical database and invited via email to participate.

Primary outcomes

  1. Personal experience of the COVID19 pandemic and the discontinuation of their fertility treatment pandemic and the discontinuation

    Time frame: 1 day

    Personal experience of the COVID19 pandemic and the discontinuation of their fertility treatment, via a survey

Secondary outcomes

  1. Risk assessment

    Time frame: 1 day

    . Risk assessment by the patient, via a survey, regarding SARS-CoV-2 during a fertility treatment or during pregnancy. Perception of the risks linked to SARS-CoV-2 during their fertility treatment or during a pregnancy

  2. Patients'expectations regarding the management of an abrupt closure of the fertility center

    Time frame: 1 day

    Patients'expectations regarding the management of an abrupt closure of the fertility center, via a survey

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Assessing the Perception and the Personal Experience of the COVID19 Pandemic Among Infertile Couples Undergoing Assisted Reproductive Treatment (ART)

Acronym: COVAPEX

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jul 2, 2020
Registry last updated
Dec 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.